Fusion Pharmaceuticals Inc. Accumulated Other Comprehensive Income
Fusion Pharmaceuticals Inc. had Accumulated Other Comprehensive Income of -$582.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-05-07
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$582.00K.
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $237.00K.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$841.00K.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$252.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2024-03-31 | -$582.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $237.00K 10-Q · filed 2024-05-07 |
| 2023-09-30 | -$841.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$252.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$85.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$469.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | -$1.26M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.06M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$578.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$115.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $63.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $337.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $283.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $44.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | -$1.00K 10-Q · filed 2020-11-10 |